Using Zamidine eye drops to prevent infections during eye surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of Zamidine® eye drops in reducing ocular surface bacterial flora in patients scheduled for various ophthalmic surgeries, including cataract surgery and vitrectomy. Data will be collected from patients with a history of recurrent conjunctivitis, focusing on swabs taken before and after surgery to assess bacterial load. The study will analyze the incidence of endophthalmitis and compare the results with standard antiseptic procedures using iodopovidone. Patient medical records will be pseudonymized to ensure confidentiality while gathering relevant data.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age 18 years or older, male and female;
2. Patient requiring ophthalmic surgery (intravitreal injections, glaucoma surgery, cataract surgery, vitrectomy, combined cataract and vitrectomy, corneal transplantation) and in need of antiseptic surgical prophylaxis (e.g., Zamidine®)
3. Positive history of recurrent conjunctivitis in the eye requiring surgery.
4. Written informed consent.

Exclusion Criteria:

1. Age \< 18 years;
2. Refusal to give informed consent.

Where it's running

• Prof. Stanislao Rizzo
  Rome, Italy Recruiting

Study contacts

• Study coordinator: Stanislao Rizzo, MD, Prof
• Email: oculistica@policlinicogemelli.it
• Phone: 0630151

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Smartphone-based AI eye disease screening for anterior segment conditions

  A smartphone-powered AI system tests whether it can identify 16 eye conditions from images captured on a phone, without needing internet access, in adults.

  Recruiting Zhongshan Ophthalmic Center, Sun Yat-sen University · Guangzhou, Guangdong · NCT07634913

• Evaluating and treating eye diseases

  This study is testing standard treatments for different eye diseases in people to see how well they work and to gather information for future research.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT02821767

• How cinema sessions during chemotherapy might help cervical cancer patients

  We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07902180

• Ophthalmic Artery Doppler to predict labor problems before induction

  This study tests whether measuring the ophthalmic artery Doppler in pregnant people at term who are being induced can help predict intrapartum fetal distress.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome, rm · NCT07846137

• GCP-R3 Practice Survey for Italian Clinical Researchers

  Researchers in Italy are taking a web survey to see how well they understand and apply GCP E6(R3) and to identify barriers and training needs.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome, Lazio · NCT07837895

• Longitudinal profiling of plasma-derived glial extracellular vesicles in Alzheimer's disease

  This study tests whether plasma glial extracellular vesicles and neuroinflammation biomarkers change over time across the Alzheimer’s disease spectrum and whether these signals relate to amyloid, tau, and neurodegeneration, with an additional step of exposing healthy iPSC-derived neurons to vesicles to see potential ne

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT07803055

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.